In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma

SIMPLE SUMMARY: Glioblastoma (GBM) is an aggressive type of brain cancer, with which only 25% of patients survive for more than one year. Treatment of GBM has remained a challenge due to its resistance to chemotherapy. Here, we aimed to assess the potential for a combination therapy of cold atmosphe...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Vikas, Adhikari, Manish, Simonyan, Hayk, Lin, Li, Sherman, Jonathan H., Young, Colin N., Keidar, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430547/
https://www.ncbi.nlm.nih.gov/pubmed/34503293
http://dx.doi.org/10.3390/cancers13174485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430547/
https://www.ncbi.nlm.nih.gov/pubmed/34503293
http://dx.doi.org/10.3390/cancers13174485

Ejemplares similares